New drug approval: Telitacicept On March 12, the State Food and Drug Administration in China issued an announcement, authorizing conditional approval for RemeGen’s therapeutic biological product for injection, Telitacicept. The drug is an innovative drug TACl-Fc...
BeiGene Co., Ltd 2019 Revenue: US$ 428.21 million Number of Employees: 4,200+ Founded: 2010 Overview BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to...
Recent Comments